Related Experiment Video
Updated: Jun 18, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Homocysteine modifies fibrin clot deformability: another possible explanation of harm
Ana María Rojas1, Lucía Kordich, Ana María Lauricella
1Department of Industry, School of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina.
Abstract:
Several studies have associated elevated plasma homocysteine (Hcy) levels with higher risk of thrombosis. In order to evaluate possible changes in fibrin strength and deformability mediated by Hcy, the effect of the amino acid on plasma fibrin clot was studied, measuring the viscoelastic clots response as a function of Hcy concentration added to plasma (final concentrations: 0, 50, 100, 250 and 500 microM). Storage (G') and loss (G'') moduli were significantly higher than control at all Hcy concentrations evaluated in a dose-independent way (G'50 microM Hcy=254+/-10 Pa vs. 178 +/- 30 Pa, p=0.012; G''50 microM Hcy=32+/-1 Pa vs. 24 +/- 2 Pa, p=0.012). The tangent of the phase shift angles tan delta obtained from Hcy-clots with respect to control system proved to be unchanged (tan delta50 microM Hcy=0.130+/-0.007 Pa vs. 0.150 +/- 0.020 Pa, NS). Increases observed in G' and G'' values allowed us to conclude that Hcy action led to the stiffening of the clots formed in a dose independent way. The higher crosslinking of the fibrin network (higher G') contributed both to this structural behavior and to a higher compartmentalization and viscosity of the fluid phase (higher G'') of the gel. The lower deformability of the clots formed after Hcy addition was also detected through deformation sweep assays. These material's characteristics may lead to pathological behavior, increasing the chances of obstruction in the blood vessels.
More Related Videos
Related Concept Videos
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

